Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1987 Dec;58(6):572–582. doi: 10.1136/hrt.58.6.572

Mortality in heart failure: clinical variables of prognostic value.

J G Cleland 1, H J Dargie 1, I Ford 1
PMCID: PMC1277308  PMID: 2447925

Abstract

One hundred and fifty two patients with chronic heart failure caused primarily by left ventricular dysfunction were followed prospectively in an open study for a mean period of 21 months. The effects of several clinical variables on subsequent outcome were examined, including the effects of treatment, which was determined by the clinician caring for the patient and was not randomly allocated. In order of importance, frequent ventricular extrasystoles, non-treatment with amiodarone, low mean arterial pressure, and a diagnosis of coronary artery disease were associated with a poor prognosis, with each of these variables providing extra predictive information independently of the others. Initial serum potassium concentration and treadmill exercise time also carried further weak but independent prognostic information. Neither treatment with angiotensin converting enzyme inhibitors nor digoxin appeared to affect outcome. Left ventricular function (as reflected by M mode echocardiography) and the dose of diuretic also failed to predict outcome. There did, however, appear to be a reduction in the frequency of sudden death when angiotension converting enzyme inhibitors were given. Further studies are required to confirm the adverse prognostic significance of ventricular arrhythmias in patients with heart failure and the possible benefit associated with amiodarone treatment.

Full text

PDF
572

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bigger J. T., Jr, Fleiss J. L., Kleiger R., Miller J. P., Rolnitzky L. M. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 1984 Feb;69(2):250–258. doi: 10.1161/01.cir.69.2.250. [DOI] [PubMed] [Google Scholar]
  2. Chakko C. S., Gheorghiade M. Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy. Am Heart J. 1985 Mar;109(3 Pt 1):497–504. doi: 10.1016/0002-8703(85)90554-x. [DOI] [PubMed] [Google Scholar]
  3. Cleland J. G., Dargie H. J., Ball S. G., Gillen G., Hodsman G. P., Morton J. J., East B. W., Robertson I., Ford I., Robertson J. I. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J. 1985 Sep;54(3):305–312. doi: 10.1136/hrt.54.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cleland J. G., Dargie H. J., East B. W., Robertson I., Hodsman G. P., Ball S. G., Gillen G., Robertson J. I., Morton J. J. Total body and serum electrolyte composition in heart failure: the effects of captopril. Eur Heart J. 1985 Aug;6(8):681–688. doi: 10.1093/oxfordjournals.eurheartj.a061920. [DOI] [PubMed] [Google Scholar]
  5. Cleland J. G., Dargie H. J., Findlay I. N., Wilson J. T. Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure. Br Heart J. 1987 May;57(5):436–445. doi: 10.1136/hrt.57.5.436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cleland J. G., Dargie H. J., Robertson I., Robertson J. I., East B. W. Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension. Br Heart J. 1987 Sep;58(3):230–238. doi: 10.1136/hrt.58.3.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  8. Cohn J. N., Levine T. B., Olivari M. T., Garberg V., Lura D., Francis G. S., Simon A. B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984 Sep 27;311(13):819–823. doi: 10.1056/NEJM198409273111303. [DOI] [PubMed] [Google Scholar]
  9. Convert G., Delaye J., Beaune J., Biron A., Gonin A. Etude pronostique des myocardiopathies primitives non obstructives. Arch Mal Coeur Vaiss. 1980;73(3):227–237. [PubMed] [Google Scholar]
  10. Creager M. A., Faxon D. P., Halperin J. L., Melidossian C. D., McCabe C. H., Schick E. C., Ryan T. J. Determinants of clinical response and survival in patients with congestive heart failure treated with captopril. Am Heart J. 1982 Nov;104(5 Pt 2):1147–1154. doi: 10.1016/0002-8703(82)90043-6. [DOI] [PubMed] [Google Scholar]
  11. Ellenbogen K. A., O'Callaghan W. G., Colavita P. G., Smith M. S., German L. D. Cardiac function in patients on chronic amiodarone therapy. Am Heart J. 1985 Aug;110(2):376–381. doi: 10.1016/0002-8703(85)90159-0. [DOI] [PubMed] [Google Scholar]
  12. Ferlinz J., Easthope J. L., Aronow W. S. Effects of verapamil on myocardial performance in coronary disease. Circulation. 1979 Feb;59(2):313–319. doi: 10.1161/01.cir.59.2.313. [DOI] [PubMed] [Google Scholar]
  13. Follansbee W. P., Michelson E. L., Morganroth J. Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac death. Ann Intern Med. 1980 Jun;92(6):741–747. doi: 10.7326/0003-4819-92-6-741. [DOI] [PubMed] [Google Scholar]
  14. Franciosa J. A., Park M., Levine T. B. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol. 1981 Jan;47(1):33–39. doi: 10.1016/0002-9149(81)90286-1. [DOI] [PubMed] [Google Scholar]
  15. Franciosa J. A., Wilen M., Ziesche S., Cohn J. N. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 1983 Mar 1;51(5):831–836. doi: 10.1016/s0002-9149(83)80141-6. [DOI] [PubMed] [Google Scholar]
  16. Furberg C. D., Yusuf S. Effect of vasodilators on survival in chronic congestive heart failure. Am J Cardiol. 1985 Apr 1;55(8):1110–1113. doi: 10.1016/0002-9149(85)90756-8. [DOI] [PubMed] [Google Scholar]
  17. Fuster V., Gersh B. J., Giuliani E. R., Tajik A. J., Brandenburg R. O., Frye R. L. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol. 1981 Mar;47(3):525–531. doi: 10.1016/0002-9149(81)90534-8. [DOI] [PubMed] [Google Scholar]
  18. Glover D. R., Littler W. A. Factors influencing survival and mode of death in severe chronic ischaemic cardiac failure. Br Heart J. 1987 Feb;57(2):125–132. doi: 10.1136/hrt.57.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Graboys T. B., Lown B., Podrid P. J., DeSilva R. Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs. Am J Cardiol. 1982 Sep;50(3):437–443. doi: 10.1016/0002-9149(82)90307-1. [DOI] [PubMed] [Google Scholar]
  20. Gradman A. H., Cunningham M., Harbison M. A., Berger H. J., Zaret B. L. Effects of oral digoxin on ventricular ectopy and its relation to left ventricular function. Am J Cardiol. 1983 Mar 1;51(5):765–769. doi: 10.1016/s0002-9149(83)80130-1. [DOI] [PubMed] [Google Scholar]
  21. Holmes J., Kubo S. H., Cody R. J., Kligfield P. Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol. 1985 Jan 1;55(1):146–151. doi: 10.1016/0002-9149(85)90317-0. [DOI] [PubMed] [Google Scholar]
  22. Huang S. K., Messer J. V., Denes P. Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: observations in 35 patients. Am J Cardiol. 1983 Feb;51(3):507–512. doi: 10.1016/s0002-9149(83)80089-7. [DOI] [PubMed] [Google Scholar]
  23. Josephson M. A., Kaul S., Hopkins J., Kvam D., Singh B. N. Hemodynamic effects of intravenous flecainide relative to the level of ventricular function in patients with coronary artery disease. Am Heart J. 1985 Jan;109(1):41–45. doi: 10.1016/0002-8703(85)90413-2. [DOI] [PubMed] [Google Scholar]
  24. McKee P. A., Castelli W. P., McNamara P. M., Kannel W. B. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971 Dec 23;285(26):1441–1446. doi: 10.1056/NEJM197112232852601. [DOI] [PubMed] [Google Scholar]
  25. McKenna W. J., Krikler D. M., Goodwin J. F. Arrhythmias in dilated and hypertrophic cardiomyopathy. Med Clin North Am. 1984 Jul;68(4):983–1000. doi: 10.1016/s0025-7125(16)31110-5. [DOI] [PubMed] [Google Scholar]
  26. Meinertz T., Hofmann T., Kasper W., Treese N., Bechtold H., Stienen U., Pop T., Leitner E. R., Andresen D., Meyer J. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol. 1984 Mar 15;53(7):902–907. doi: 10.1016/0002-9149(84)90522-8. [DOI] [PubMed] [Google Scholar]
  27. Mestroni L., Fonda F., Camerini F. Ventricular arrhythmias in congestive cardiomyopathy. N Engl J Med. 1983 Aug 11;309(6):377–378. doi: 10.1056/NEJM198308113090614. [DOI] [PubMed] [Google Scholar]
  28. Milner P. G., Platia E. V., Reid P. R., Griffith L. S. Ambulatory electrocardiographic recordings at the time of fatal cardiac arrest. Am J Cardiol. 1985 Oct 1;56(10):588–592. doi: 10.1016/0002-9149(85)91016-1. [DOI] [PubMed] [Google Scholar]
  29. Packer M., Medina N., Yushak M. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure. Circulation. 1984 Dec;70(6):1038–1047. doi: 10.1161/01.cir.70.6.1038. [DOI] [PubMed] [Google Scholar]
  30. Packer M., Medina N., Yushak M., Meller J. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure. Circulation. 1983 Oct;68(4):803–812. doi: 10.1161/01.cir.68.4.803. [DOI] [PubMed] [Google Scholar]
  31. Poll D. S., Marchlinski F. E., Buxton A. E., Doherty J. U., Waxman H. L., Josephson M. E. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy. Circulation. 1984 Sep;70(3):451–456. doi: 10.1161/01.cir.70.3.451. [DOI] [PubMed] [Google Scholar]
  32. Reddy C. P., Gettes L. S. Use of isoproterenol as an aid to electric induction of chronic recurrent ventricular tachycardia. Am J Cardiol. 1979 Oct;44(4):705–713. doi: 10.1016/0002-9149(79)90291-1. [DOI] [PubMed] [Google Scholar]
  33. Robinson C., Jackson G., Fisk C., Jewitt D. Haemodynamic effects of atenolol in patients with coronary artery disease. Br Heart J. 1978 Jan;40(1):22–28. doi: 10.1136/hrt.40.1.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Shapiro W. Correlative studies of serum digitalis levels and the arrhythmias of digitalis intoxication. Am J Cardiol. 1978 May 1;41(5):852–859. doi: 10.1016/0002-9149(78)90724-5. [DOI] [PubMed] [Google Scholar]
  35. Shirey E. K., Proudfit W. L., Hawk W. A. Primary myocardial disease. Correlation with clinical findings, angiographic and biopsy diagnosis. Follow-up of 139 patients. Am Heart J. 1980 Feb;99(2):198–207. doi: 10.1016/0002-8703(80)90766-8. [DOI] [PubMed] [Google Scholar]
  36. Shugoll G. I., Bowen P. J., Moore J. P., Lenkin M. L. Follow-up observations and prognosis in primary myocardial disease. Arch Intern Med. 1972 Jan;129(1):67–72. [PubMed] [Google Scholar]
  37. Steiness E., Olesen K. H. Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy. Br Heart J. 1976 Feb;38(2):167–172. doi: 10.1136/hrt.38.2.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Sutton R. Haemodynamics of intravenous disopyramide. J Int Med Res. 1976;4(1 Suppl):46–48. [PubMed] [Google Scholar]
  39. Szlachcic J., Massie B. M., Kramer B. L., Topic N., Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol. 1985 Apr 1;55(8):1037–1042. doi: 10.1016/0002-9149(85)90742-8. [DOI] [PubMed] [Google Scholar]
  40. Taylor S. H., Silke B. Haemodynamic effects of beta-blockade in ischaemic heart failure. Lancet. 1981 Oct 17;2(8251):835–837. doi: 10.1016/s0140-6736(81)91105-3. [DOI] [PubMed] [Google Scholar]
  41. Trobaugh G. B., Kudenchuk P. J., Greene H. L., Tutt R. C., Kingston E., Gorham J. R., Gross B. W., Graham E. L., Sears G. K., Werner J. A. Effect of amiodarone on ventricular function as measured by gated radionuclide angiography. Am J Cardiol. 1984 Dec 1;54(10):1263–1266. doi: 10.1016/s0002-9149(84)80077-6. [DOI] [PubMed] [Google Scholar]
  42. Unverferth D. V., Magorien R. D., Moeschberger M. L., Baker P. B., Fetters J. K., Leier C. V. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol. 1984 Jul 1;54(1):147–152. doi: 10.1016/0002-9149(84)90320-5. [DOI] [PubMed] [Google Scholar]
  43. Waagstein F., Hjalmarson A., Varnauskas E., Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J. 1975 Oct;37(10):1022–1036. doi: 10.1136/hrt.37.10.1022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Walsh W. F., Greenberg B. H. Results of long-term vasodilator therapy in patients with refractory congestive heart failure. Circulation. 1981 Sep;64(3):499–505. doi: 10.1161/01.cir.64.3.499. [DOI] [PubMed] [Google Scholar]
  45. Wilson J. R., Schwartz J. S., Sutton M. S., Ferraro N., Horowitz L. N., Reichek N., Josephson M. E. Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol. 1983 Sep;2(3):403–410. doi: 10.1016/s0735-1097(83)80265-4. [DOI] [PubMed] [Google Scholar]
  46. von Olshausen K., Schäfer A., Mehmel H. C., Schwarz F., Senges J., Kübler W. Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J. 1984 Feb;51(2):195–201. doi: 10.1136/hrt.51.2.195. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES